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Uncommon Treatment of Mononeuritis Multiplex in a 37-year-old Male
Nicole Daver, DO; Ankush Sharma, MD; Manjeera Cherukuri, MD
Lehigh Valley Health Network, Allentown, Pennsylvania

Introduction:

Mononeuritis multiplex is a painful condition characterized by asymmetric
loss of sensory and motor function of individual peripheral nerves. It is
a common presentation of a multitude of conditions, including diabetes
mellitus, vasculitis, infections and various autoimmune disorders.

Case Presentation:

A 37-year-old Caucasian male with a history of hypertension secondary
to autosomal dominant polycystic kidney disease (ADPKD) presented
to the emergency department with a three-month history of progressive
lower extremity weakness and paresthesias, leading to severe ambulatory
dysfunction. Physical exam revealed stocking and glove pattern weakness
in the distal upper and lower extremities bilaterally, along with severe pain
to palpation. Diagnostic studies of an MRI of the brain and lumbar puncture
were unremarkable. Laboratory data showed an elevated creatinine,
transaminitis, an erythrocyte sedimentation rate of 80 and proteinuria. ELISA
for HIV was negative, however, hepatitis B serology was positive for both
surface and envelope antigens, indicating active viral replication. Suspicion
for a vasculitic etiology of his symptoms led to an EMG and sural nerve
biopsy, both of which had findings consistent with vasculitis. Collectively, his
symptoms and diagnostic data met the criteria for polyarteritis nodosa (PAN),
a vasculitis of medium-sized vessels. Treatment of PAN typically involves
corticosteroids and the immunosuppressant medication, cyclophosphamide,
with close monitoring of renal function. However, when PAN presents
concurrently with active hepatitis B, the combination of corticosteroids,
antiviral therapy and plasmapheresis is more favorable and was the course
of action taken in this case. Upon discharge, the patient was continued
on Entecavir, an antiviral therapy for chronic hepatitis B. Within weeks, the
patient’s paresthesias decreased, allowing him to ambulate with a cane.

American College of Rheumatology 1990 criteria for the classification of polyarteritis
nodosa (PAN). Classified as PAN if at least 3 of the 10 criteria are present:
• Weight loss > 4 kg: Loss of >4 kg body weight since illness began, not related to
dieting or other factors.
• Livedo reticularis: Mottled reticular pattern over the skin of portions of the
extremities or torso.
• Testicular pain/tenderness: Pain or tenderness of the testicles, not due to infection,
trauma or other causes.
• Myalgias, weakness or leg tenderness: Diffuse myalgias (excluding shoulder or hip
girdle) or weakness of muscles or tenderness of leg muscles.
• Mono- or polyneuropathy: Development of mononeuropathy, multiple
mononeuropathies or polyneuropathy.
• Diastolic BP >90 mmHg: Development of hypertension with the diastolic BP higher
than 90 mmHg.
• Elevated BUN or creatinine: Elevation of BUN >40 mg/dl or creatinine >1.5 mg/dl,
not due to dehydration or obstruction.
• Hepatitis B virus: Presence of hepatitis B surface antigen or antibody in serum.
• Arteriographic abnormality: Arteriogram showing aneurysms or occlusions of the
visceral arteries, not due to arteriosclerosis, fibromuscular dysplasia or other noninflammatory causes.
• Biopsy of small or medium-sized artery containing polymorphonuclear cells:
Histologic changes showing the presence of granulocytes or granulocytes and
mononuclear leukocytes in the artery wall.
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Discussion:

The presentation of mononeuritis multiplex can mislead one into believing
that the patient is suffering from a central neurological deficit.  However, the
patient’s clinical presentation must be taken into account and prompt the
physician to rule out other possibilities. In this case, a viral infection likely
triggered the autoimmune disorder. Hepatitis B-associated PAN has been
documented but is on the decline secondary to hepatitis vaccinations. It
is believed that the viral antigen and antibody form an immune complex
that is deposited in the vessel wall, leading to inflammation. In hepatitis Bassociated PAN, plasmapheresis has been demonstrated to be effective
in removing circulating immune complexes and may lead to hepatitis B
seroconversion, thus leading to a more favorable outcome. Our patient’s viral
load was undetectable after weeks of antiviral therapy and correlated with
his clinical improvement, proving that the combination of corticosteroids,
plasmapheresis and antiviral therapy are effective in treatment of hepatitis Bassociated PAN.

Source: Lightfoot RW, et al. “The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa.” Arthritis and
Rheumatism.  33:1088-1093. 1990.
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Image A: High powered vessel biopsy
demonstrating transmural inflammatory cell
infiltrates consistent with vasculitis.

Image B: Thick section thrombosed vessel
with surrounding inflammation consistent
with vasculitis.

Image C: Thick section nerve fascicle
demonstrating selective depopulation of
myelin fibers.

Source: Case report patient

Source: Case report patient

Source: Case report patient

Cacoub, P. et al. “Hepatitis B-Related Autoimmune Manifestations”. Rheumatic Disease Clinics of North America. 35:125-137, 2008
Castelino, F. et al. “A 36-Year-Old Man With Paresthesias and a Headache”.  Arthritis and Rheumatism. 59(9):1358-1365, 2008
Firestein, G. et al. Kelley’s Textbook of Rheumatology, 8th edition. Volume II, Chapter 83, 2008
Guillevin, L. et al. “Hepatitis B Virus-Associated Polyarteritis Nodosa: Clinical Characteristics, Outcome, and Impact of Treatment in 115 Patients”.
Medicine. 84(5): 313-322, 2005.
5 Guillevin, L. et al, “Short-Term Corticosteroids Then Lamivudine and Plasma Exchanges to Treat Hepatitis B Virus–Related Polyarteritis Nodosa”. Arthritis
and Rheumatism 51(3) Arthritis Care & Research, 482–487, 2004.
6 Guillevin, L. et al. “Treatment of Polyarteritis Nodosa related Hepatitis B virus with interferon-alpha and plasma exchange”.  Annals of the Rheumatic
Diseases.  53, 334-337.  1994.
7 Lightfoot RW, et al. “The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa.” Arthritis and Rheumatism.  
33:1088-1093. 1990.

